Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06162884 · ClinicalTrials.gov registry record
Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
A clinical trial of Pulmonary Fibrosis, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06162884 is a study of Pulmonary Fibrosis that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 200 participants, below the 880-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06162884, a study of Pulmonary Fibrosis, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a prospective observational study for subjects with idiopathic pulmonary fibrosis (IPF) or non-IPF interstitial lung diseases (ILD). The purpose of this study is to compare whether imaging patterns from high-resolution computed tomography (HRCT) at baseline can predict worsening. Single Time point Prediction (STP) is a score derived from an artificial intelligenc/ machine learning (AI/ML) using the radiomic features from a HRCT scan that quantifies the imaging patterns of short-term predictive worsening.
Conditions Studied
Study Locations (1)
California
- UCLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-11-06 |
| Est. Completion | 2028-08-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06162884
The ClinicalTrials.gov registry entry for NCT06162884 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 880-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (77% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Fibrosis appearing as the primary indexed condition, and to 0 interventions.
NCT06162884 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06162884 about?
NCT06162884 is a clinical study titled "Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis". This study is a prospective observational study for subjects with idiopathic pulmonary fibrosis (IPF) or non-IPF interstitial lung diseases (ILD). The purpose of this study is to compare whether imaging patterns from high-resolution computed tomography (HRCT) at baseline can predict worsening. Sing...
What is the current status of trial NCT06162884?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-11-06. Estimated completion is 2028-08-19.
What conditions does trial NCT06162884 study?
This clinical trial studies the following conditions: Pulmonary Fibrosis.
Who is sponsoring clinical trial NCT06162884?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06162884 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advanced Imaging for Pulmonary Fibrosis
RECRUITING · Phase 2
-
Pulmonary Fibrosis Foundation Community Registry
RECRUITING
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
-
FAPI PET for Lung Fibrosis
RECRUITING · Early Phase 1
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
-
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.